Table 1.
Clinical and pathological data of the patients enrolled in the study
| Number of cases (%) | Radiosensitive | Radioresistant | X2 (p value) | |
|---|---|---|---|---|
| n (%) | n (%) | |||
| Gender | ||||
| Male | 30 (88.2) | 12 (40.0) | 18 (60.0) | 1.0 |
| Female | 4 (11.8) | 2 (50.0) | 2 (50.0) | |
| Age | ||||
| ≤60 years | 16 (47.1) | 5 (31.2) | 11 (68.8) | 0.51 |
| >60 years | 18 (52.9) | 9 (50.0) | 9 (50.0) | |
| Tobacco consumption | ||||
| Yes | 31 (91.2) | 14 (45.2) | 17 (54.8) | 0.25 |
| No | 3 (8.8) | 0 (0) | 3 (100.0) | |
| Tumor site | ||||
| Supraglottic | 7 (20.6) | 2 (28.6) | 5 (71.4) | 1.0 |
| Glottic | 27 (79.4) | 12 (44.4) | 15 (55.6) | |
| Tumor stage | ||||
| I | 16 (47.1) | 8 (50) | 8 (50) | 0.49 |
| II | 18 (52.9) | 6 (33.3) | 12 (66.7) | |
| Radiotherapy dose | ||||
| <70 Gy | 10 (29.4) | 5 (50.0) | 5 (50.0) | 0.7 |
| ≥70 Gy | 24 (70.6) | 9 (37.5) | 15 (62.5) | |
| Treatment time | ||||
| ≤55 days | 20 (58.8) | 9 (45.0) | 11 (55.0) | 0.72 |
| >55 days | 14 (41.2) | 5 (37.5) | 9 (64.3) | |